| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:06 | C3is Inc. prices $9 million public offering of common stock units | ||
| 15:06 | SEALSQ enters healthcare sector with medical device chip technology | ||
| 15:06 | Klarna partners with Privy to explore crypto wallet solutions | ||
| 15:06 | Research Solutions announces CFO transition as Nurthen departs | ||
| 15:06 | NetraMark secures contract for Phase 3 trial analytics from global pharma | ||
| 15:06 | Commvault and Delinea partner to strengthen credential security | ||
| 15:06 | Baxter reports safety improvements with smart infusion pump integration | ||
| 15:06 | Vivakor reduces debt by $65 million, strengthens balance sheet | ||
| 15:06 | Planet Labs stock price target raised to $16 from $14 at Clear Street | ||
| 14:42 | Geode Capital discloses 2.25% stake in Avadel Pharmaceuticals | ||
| 14:42 | SLB partners with Shell to develop AI solutions for energy operations | ||
| 14:42 | Surgery Partners to offer $425 million in senior unsecured notes | ||
| 14:42 | Massimo Group to showcase climate-controlled electric vehicles at 2026 PGA Show | ||
| 14:42 | Asteriscos Patrimonial acquires 32% stake in PayPoint | ||
| 14:42 | RedCloud reports 28% TTV growth, cuts liabilities by $65M in H1 2025 | ||
| 14:42 | Cerence AI launches new conversational agents for auto industry | ||
| 14:42 | Aligos reports synergistic weight loss effect with THR-ß agonist | ||
| 14:42 | GIBO to develop 30MW AI data center with 14,000-GPU cluster in Malaysia | ||
| 14:42 | Banglalink secures payment service provider license in Bangladesh | ||
| 14:42 | Stifel reiterates Hold rating on Federal Realty Investment Trust stock | ||
| 14:42 | Seaport Global Securities downgrades GE Vernova stock to Neutral from Buy | ||
| 14:42 | Exelixis stock holds steady as Stifel maintains $43 price target | ||
| 14:42 | Stifel raises argenx stock price target to $1,248 on Vyvgart dominance | ||
| 14:42 | Stifel reiterates Buy rating on Adobe stock, maintains $450 price target | ||
| 14:42 | AnaptysBio stock price target lowered to $56 by Stifel on Jemperli sales outlook |